The Next Generation Biotech Media
When a company enters the stock market, it allows the public to trade its shares. An Initial Public Offering (IPO) allows companies to offer new stocks to the investors and …
Read More
Over the last two decades, significant progress has been made in cancer therapeutics, but significant challenges remain. At the BIO CEO and Investor Digital Conference, experts from leading companies discussed …
Read More
Tessera Therapeutics, a Boston-based life science startup raised $230M in Series B financing. Incubated at Flagship Labs since 2018, Tessera debuted in 2020 with a $50M investment to innovate …
Read More
Aro Biotherapeutics, which specializes in the development of tissue-targeted genetic medicines, announced on January 5th that it has managed to secure $88 million in Series A financing from several venture …
Read More
The new year has brought good news for Boston-based Ikena oncology, which raised $120 million to push its pipeline of patient-specific, next-generation targeted oncology and immunometabolism therapies. This funding comes …
Read More
On December 14th, Locanabio announced it had raised $100 million in a Series B financing. The funding will be used to advance the pre-clinical and clinical development of their CRISPR-mediated …
Read More
Neuron23 Inc., founded in 2018 through a partnership with German biotechnology company, Origenis GmbH, has recently come out of stealth mode. Origenis develops precision medicine for genetically defined neurological and …
Read More
On December 7th, Roivant biosciences unveiled its novel protein degradation platform, powered by VantAI and supported by SK Holdings, a South Korean Investment group. VantAI is a drug discovery platform …
Read More
The COVID-19 pandemic has hurried the development of telemedicine, precision medicine, and several online platforms. The latest in that line is JD Health, China’s biggest online healthcare platform, which made …
Read More
In a bid to push Merrimack’s dropout drug seribantumab through Phase 2, Elevation Oncology has raised $65 M in a Series B financing round, led by new investors venBio Partners …
Read More